Violet Research Institute (VRI) is an independent research institute based in New York, focused on advancing understanding and treatment of human genetic disease. Privately funded and committed to openly sharing its work, VRI aims to build research and infrastructure that can support lasting progress. Its approach begins with an individual patient: each program starts with a person and a scientific question their biology can help answer. By treating genetic disease as a shared biological mechanism rather than grouping conditions under the label “rare,” the institute seeks to identify common pathways and make its infrastructure reusable across diseases.

VRI works to connect frontier science with clinical care and patients, addressing the gap between scientific knowledge and available medicine. Its research includes primary investigations, with a research brief on SYT1-T1103C presented on its website. The institute also highlights a pipeline, a fellowship, grants, and collaborations with people and partners as part of its research ecosystem.